Document is current
Any future updates will be listed below
-
Authors
Baumann, Anja
Nier, Anika
Hernández-Arriaga, Angélica
Brandt, Annette
Lorenzo Pisarello, Maria J.
Jin, Cheng J.
Pilar, Esther
Camarinha-Silva, Amélia
Schattenberg, Jörn M.
Bergheim, Ina
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (FKZ 01GI1122H)
- License Information
-
More Information
Article History
Received: 10 June 2021
Accepted: 17 August 2021
First Online: 8 September 2021
Competing interests
: J.M.S. serves as a consultant or advisory board member for Boehringer Ingelheim, Bristol-Myer Squibb, Echosens, Gilead, Genfit, Intercept, IQVIA, Madrigal, Nordic Bioscience, Novartis, Novo Nordisk, Pfizer, Siemens Healthineers. In addition, his institution has received grant support from Gilead Sciences and Yakult Deutschland. I.B. received funding of Yakult. All other authors declare no conflict of interests.
